EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 9.2% of their position (5.90K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $1.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/15/2026ACC: 0001493152-26-042754
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+5.90K
Net shares
Net buyer
$1.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5.90K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.90K
Price / share
$0.22
Trade value
$1.29K
% of position
9.2%
9/14/2026
63.92K→69.82K
Total
Net shares
+5.90K
Net value
$1.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2026 | P · Purchase | +5.90K | $0.22 | $1.29K | 9.2% | 63.92K | 69.82K |
| Total | +5.90K | $1.29K | ||||||
Derivative Transactions0
No derivative transactions reported